Fundz

Cyllene Therapeutics Appoints Marc Grasso as Chief Financial Officer

PRIVATESep 17, 2026

Position

Chief Financial Officer

Company

Cyllene Therapeutics

Marc Grasso
ParisBiotechnologyHealth CareTherapeutics

Description

Cyllene Therapeutics has announced the appointment of Dr. Marc Grasso as Executive Vice-President and Chief Financial Officer. Dr

Quick answer

Cyllene Therapeutics Appoints Marc Grasso as Chief Financial Officer (September 17, 2026). Cyllene Therapeutics is based in Paris, Ile-de-France, France.

Who is the new Chief Financial Officer at Cyllene Therapeutics?
Cyllene Therapeutics named Marc Grasso Chief Financial Officer, announced September 17, 2026.
What did Cyllene Therapeutics announce on September 17, 2026?
Cyllene Therapeutics has announced the appointment of Dr. Marc Grasso as Executive Vice-President and Chief Financial Officer.
What does Cyllene Therapeutics do?
Cyllene Therapeutics, formerly known as EG 427, is a clinical-stage biotechnology company focused on the development of precision genetic medicines for neurological diseases.
Where is Cyllene Therapeutics based?
Cyllene Therapeutics is based in Paris, Ile-de-France, France.
Which similar companies made leadership changes around the same time?
Paradigm Biopharmaceuticals (September 17, 2026), Oxford Brain Diagnostics (September 15, 2026), AdvanCell (September 15, 2026) and Serapha Bio (September 15, 2026) also announced leadership changes within 45 days of Cyllene Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Cyllene Therapeutics, and when

A new leader at Cyllene Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Cyllene Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cyllene Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cyllene Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cyllene Therapeutics

Location

Paris, Ile-de-France, France

About

Cyllene Therapeutics, formerly known as EG 427, is a clinical-stage biotechnology company focused on the development of precision genetic medicines for neurological diseases. The company is known for its HERMES technology, which facilitates safe and targeted delivery of therapeutic DNA. Cyllene Tx aims to advance its lead candidate, EG110A, for chronic indications in neuro-urology. The company has garnered significant funding to support its clinical development and pipeline expansion.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cyllene Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Cyllene Therapeutics's next move

Learn about Strategic plan

Cyllene Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.